Cogent Biosciences, Inc. (COGT) stock
COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.85+0.41 (+1.49%)
Close on Nov 17, 2026Market cap $4.83BP/E –Yield –
Cogent Biosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cogent Biosciences's total debt was $44.25M at Sep 30, 2025. For fiscal 2024 it was $0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $44.25M | – |
| Q2 FY2025 | Jun 30, 2025 | $43.95M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
See a number that looks wrong?